Rutatsid

Rutatsid - antacid.

Structure and Composition

Rutatsid produced in the form of chewable tablets. Each tablet contains the active substance - 500 mg of hydrotalcite.

 Rutatsid tablets

Auxiliary components: mint flavor, sodium saccharinate, magnesium stearate, mannitol, talc, sodium carboxymethyl starch.

10 pieces per pack.

Pharmacological action

The active substance is Rutatsida layered network structure with a low content of magnesium and aluminum. Depending on the pH of the gastric juice occurs gradual release of magnesium and aluminum. Rutatsid provides continuous neutralization of hydrochloric acid with the maintenance of a normal pH level. Protect the gastric mucosa, it binds bile acids, reduces the proteolytic activity of pepsin.

Indications Rutatsida

According to the instructions Rutatsid shown in the following cases:

  • heartburn;
  • stomach ulcers and 12 duodenal ulcer;
  • reflux esophagitis;
  • gastric hyperacidity;
  • gastritis.

Contraindications

According to the instructions Rutatsid contraindicated in children under 6 years as well as in case of hypersensitivity to the drug.

Be wary appoint Rutatsid according to the instructions in the hypophosphatemia and chronic renal failure.

Dosing and dosing regimen Rutatsida

According to the instructions Rutatsid taken orally. Tablets are chewed carefully.

Children over 12 and adults take 1-2 Valium. three to four times a day, one hour after meals and at bedtime.

Children 6 to 12 years old to take 1 tab. twice a day.

Duration of treatment - one month.

side effects

Application Rutatsida at recommended doses rarely causes side effects. You may experience belches, allergic reactions, diarrhea.

 Rutatsid in carton

Drug Interactions

According to the instructions Rutatsid while the use of fluoroquinolones, tetracyclines, oral anticoagulants, drugs reduces their absorption of iron.

Application Rutatsida during pregnancy and breastfeeding

According to the instructions Rutatsid can be taken during pregnancy at a ratio of benefits and risks for mother and child.

Breastfeeding drug approved for use, as its active ingredient penetrates into breast milk.

storage conditions

Keep it in a dry place away from children for no longer than five years.





Яндекс.Метрика